Tethys Bioscience announced that the PreDx test can now be performed using capillary blood collected from a simple finger stick procedure. PreDx is a multi-biomarker blood test used to stratify and monitor patients with prediabetes.
The PreDx test measures seven biomarkers (glucose, hemoglobin A1C, insulin, adiponectin, C-Reactive Protein, Ferrtin and Interleukin 2-Reactive alpha) involved in the development of type 2 diabetes, and utilizes a proprietary algorithm to rank a prediabetic patient’s 5-year risk of progression to diabetes (score 1–10).
Baseline scores are used to stratify prediabetes patients into low, moderate, or high-risk categories for disease progression. Retests are used to monitor changes in the patient’s score, which demonstrate efficacy of preventative measures taken to reduce the patient’s risk.
Clinical data showed that the precision and accuracy of PreDx tests performed with capillary blood was equivalent to that of the PreDx test using venous blood. The PreDx test using capillary blood also showed statistical significance over fasting glucose alone for predicting the development of type 2 diabetes.
For more information call (888) 697-7339 or visit PreDxDiabetes.com.